Koucky, K; Wein, A; Konturek, PC et al.
Palliative first-line therapy with weekly high-dose 5-fluorouracil and sodium folinic acid as a 24-hour infusion (AIO regimen) combined with weekly irinotecan in patients with metastatic adenocarcinoma of the stomach or esophagogastric junction followed by secondary metastatic resection after downsizingMEDICAL SCIENCE MONITOR. Bd. 17. H. 5. 2011 S. CR248-CR258
Marker-Hermann, E
Para-neoplastic Symptoms in RheumatologyZEITSCHRIFT FUR RHEUMATOLOGIE. Bd. 70. H. 7. 2011 S. 553-553
Zeuzem, S; Arora, S; Bacon, B et al.
PEGYLATED INTERFERON-LAMBDA (PEGIFN-lambda) SHOWS SUPERIOR VIRAL RESPONSE WITH IMPROVED SAFETY AND TOLERABILITY VERSUS PEGIFN alpha-2A IN HCV PATIENTS (G1/2/3/4): EMERGE PHASE IIB THROUGH WEEK 12JOURNAL OF HEPATOLOGY. Bd. 54. 2011 S. S538-S539
Huang, YW; Sprinzl, M
Peptide Bond Formation on the Ribosome: The Role of the 2 '-OH Group on the Terminal Adenosine of Peptidyl-tRNA and of the Length of Nascent Peptide ChainANGEWANDTE CHEMIE-INTERNATIONAL EDITION. Bd. 50. H. 32. 2011 S. 7287-7289
Rossol, S; Schuchmann, M; Mauss, S et al.
PHARMAECONOMIC EVALUATION OF CHRONIC HCV TREATMENT WITH PEGINTERFERON ALFA-2A/RIBAVIRN - REAL LIFE SETTING IN A LARGE GERMAN COHORT OF 1147 PATIENTSHEPATOLOGY. Bd. 54. 2011 S. 858A-859A
Kim, HS; Kim, JY; Ryu, HS et al.
Phenotypic and Functional Maturation of Dendritic Cells Induced by Polysaccharide Isolated from Paecilomyces cicadaeJOURNAL OF MEDICINAL FOOD. Bd. 14. H. 7-8. 2011 S. 847-856
Maurer, A; Schwarting, A; Kahaly, GJ
Polyglandular autoimmune syndromesZEITSCHRIFT FUR RHEUMATOLOGIE. Bd. 70. H. 9. 2011 S. 752-+
Hartmann, C; Schuchmann, M; Zimmermann, T
Posttransplant lymphoproliferative disease in liver transplantationCurr Infect Dis Rep. Bd. 13. H. 1. 2011 S. 53-9
Manns, MP; Bourliere, M; Benhamou, Y et al.
Potency, safety, and pharmacokinetics of the NS3/4A protease inhibitor BI201335 in patients with chronic HCV genotype-1 infectionJOURNAL OF HEPATOLOGY. Bd. 54. H. 6. 2011 S. 1114-1122
Mauss, S; Schober, A; Lutz, T et al.
Predictive Factors of Thrombocytopenia in Treatment of Chronic Hepatitis C (CHC) Patients With Peginterferon Alfa-2a (40KD) and RibavirinGASTROENTEROLOGY. Bd. 140. H. 5. 2011 S. S948-S948